tradingkey.logo
tradingkey.logo
Search

Avalyn Pharma Ord Shs (Proposed)

AVLN
Add to Watchlist
27.760USD
-1.910-6.44%
Market hours 09/24, 11:56ET
1.23BMarket Cap
0.00P/E TTM

AVLN Financials

See Avalyn Pharma Ord Shs (Proposed)'s financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
1.23B
Dividend TTM
0.00
P/E TTM
0.00
EPS TTM
0.00
Revenue
--
Net Profit
0.00
ROE
0.00%
ROA
0.00%

Avalyn Pharma Ord Shs (Proposed) Earnings Date

Latest Release
Aug 12, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
Financial Indicators
EPS
---0.98
---21.83
Net Profit
-43.31%-28.93M
---26.87M
Debt to assets ratio
--3.48%
--10.92%
Operating profit
-43.68%-31.29M
---27.91M
Net Profit
-43.31%-28.93M
---26.87M
Current assets
--357.99M
--129.99M
Total current liabilities
--10.81M
--11.79M
Total assets
--425.45M
--135.66M
Total liabilities
--27.10M
--27.69M
Total equity
--398.35M
--107.98M
Net operating income
-25.99%-26.08M
---29.89M
Net investment
-223.59%-118.71M
--55.02M
Net financing
252.31%316.67M
--14.86M

FAQs

What are the total assets of Avalyn Pharma Ord Shs (Proposed)?

According to Avalyn Pharma Ord Shs (Proposed)'s FY2025 earnings report, its total assets of Avalyn Pharma Ord Shs (Proposed) were 135.66M, with a year-on-year change of -8.88.

What are the total liabilities of Avalyn Pharma Ord Shs (Proposed)?

According to Avalyn Pharma Ord Shs (Proposed)'s FY2025 earnings report, its total liabilities of Avalyn Pharma Ord Shs (Proposed) were 27.69M, with a year-on-year change of 80.77.

What is the net operating income of Avalyn Pharma Ord Shs (Proposed)?

According to Avalyn Pharma Ord Shs (Proposed)'s FY2025 earnings report, its net operating income of Avalyn Pharma Ord Shs (Proposed) was -91.29M, with a year-on-year change of -59.82.

What is the net investment of Avalyn Pharma Ord Shs (Proposed)?

According to Avalyn Pharma Ord Shs (Proposed)'s FY2025 earnings report, its net investment of Avalyn Pharma Ord Shs (Proposed) was 10.06M, with a year-on-year change of 110.99.

What is the net financing of Avalyn Pharma Ord Shs (Proposed)?

According to Avalyn Pharma Ord Shs (Proposed)'s FY2025 earnings report, its net financing of Avalyn Pharma Ord Shs (Proposed) was 99.79M, with a year-on-year change of 112020.22.

What is the net income of Avalyn Pharma Ord Shs (Proposed)?

According to Avalyn Pharma Ord Shs (Proposed)'s FY2025 earnings report, its net income was -85.20M, with a year-on-year change of -71.28.

What is the operating profit of Avalyn Pharma Ord Shs (Proposed)?

According to Avalyn Pharma Ord Shs (Proposed)'s FY2025 earnings report, its operating profit was -91.29M, with a year-on-year change of -59.82.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.